Endeavor Health Joined Breast Cancer Consortium
The hospital system has partnered with the Chicago Breast Cancer Research Consortium to advance local oncology studies.
Updated on Oct. 9, 2026 in Cancer
Live Poll
Do you believe multi-institution research partnerships improve access to life-saving clinical trials in your area?
Endeavor Health has officially become the fourth partner in the Chicago Breast Cancer Research Consortium. The collaboration aims to accelerate research and increase patient access to clinical trials across the region.
Why it matters
This partnership enables institutions to share critical research data and specimens to speed up breast cancer innovation. By coordinating efforts, these centers hope to broaden the scope of available clinical trials for patients.
Endeavor Health is now the fourth research partner in the Chicago Breast Cancer Research Consortium. The group joins existing members including University of Chicago Medicine, Northwestern Medicine, and Rush University Medical Center.
The players
Endeavor Health
This hospital system operates the Evanston Hospital facility where the recent partnership announcement occurred.
Chicago Breast Cancer Research Consortium
This is a collaborative group of medical institutions that share specimens and research data to study breast cancer.
Lynn Sage Breast Cancer Foundation
This foundation serves as the organization that announced the new partnership involving Endeavor Health.
The details
The collaboration works by pooling clinical data and research specimens across the four participating medical institutions. This united approach is intended to streamline the research process and facilitate easier access to specialized care options for patients.
Timeline
The partnership announcement took place on October 8, 2026.
A second collaborative clinical trial is scheduled for launch in early fall 2026.
The Big Picture
This partnership marks a significant expansion for the Chicago Breast Cancer Research Consortium. It strengthens the network of data and specimen sharing among top regional medical centers.
Patients may gain improved access to innovative clinical trials as the four participating hospitals align their research goals. This collaboration potentially offers residents a wider range of study options for breast cancer treatments.
The takeaway
Collaborative research models allow hospitals to combine resources that would otherwise remain isolated in individual systems. Patients should discuss available clinical trials with their oncology team to see if new regional opportunities align with their treatment plans.
What happens next
The consortium is scheduled to launch a second collaborative clinical trial in early fall 2026.
Further reading
Learn more about local oncology initiatives at the Cancer section.
Source note: This article includes information reported by CBS News.
Live Poll
Do you believe multi-institution research partnerships improve access to life-saving clinical trials in your area?
